A survey of frameworks for best practices in weight-of-evidence analyses
暂无分享,去创建一个
Richard A. Becker | Julie E. Goodman | Michael Honeycutt | Greg Paoli | Norbert E. Kaminski | Roberta W. Scherer | Robyn L. Prueitt | Lorenz R. Rhomberg | R. Prueitt | N. Kaminski | R. Scherer | Nancy B. Beck | R. Becker | L. Rhomberg | J. Goodman | G. Paoli | L. Pottenger | Lynn H. Pottenger | Lisa A. Bailey | Christopher Bevan | Kimberly C. Wise | M. Honeycutt | Christopher Bevan | Kimberly Wise
[1] Ord,et al. Guidelines for Neurotoxicity Risk Assessment , 2014 .
[2] U. Epa. Guidelines for carcinogen risk assessment , 1986 .
[3] David Moher,et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews , 2007, BMC medical research methodology.
[4] L. V. van Amelsvoort,et al. A weight of evidence approach to causal inference. , 2009, Journal of clinical epidemiology.
[5] Jennifer Seed,et al. A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.
[6] Gábor L. Lövei,et al. Application of Systematic Review Methodology to Food and Feed Safety Assessments to Support Decision Making , 2010 .
[7] Abby A. Li,et al. Integration of epidemiology and animal neurotoxicity data for risk assessment. , 2012, Neurotoxicology.
[8] Julie E Goodman,et al. Hypothesis-based weight of evidence: A tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action—naphthalene as an example , 2010, Critical reviews in toxicology.
[9] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[10] H. Tilson. Guidelines for Neurotoxicity Risk Assessment , 1998 .
[11] U. Tillmann,et al. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.
[12] Richard A Becker,et al. Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program. , 2011, Regulatory toxicology and pharmacology : RTP.
[13] Pierre R. Bushel,et al. CEBS—Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data , 2007, Nucleic Acids Res..
[14] Ord,et al. Framework for Human Health Risk Assessment to Inform Decision Making , 2013 .
[15] Richard W. Lewis,et al. Recognition of Adverse and Nonadverse Effects in Toxicity Studies , 2002, Toxicologic pathology.
[16] R. Tyl. Basic Exploratory Research versus Guideline-Compliant Studies Used for Hazard Evaluation and Risk Assessment: Bisphenol A as a Case Study , 2009, Environmental health perspectives.
[17] Paolo Vineis,et al. Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. , 2012, International journal of epidemiology.
[18] Kim Boekelheide,et al. Toxicity testing in the 21st century: using the new toxicity testing paradigm to create a taxonomy of adverse effects. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[19] Sheldon Krimsky,et al. The weight of scientific evidence in policy and law. , 2005, American journal of public health.
[20] Michael S Victoroff,et al. Evidence-based toxicology: a comprehensive framework for causation , 2005, Human & experimental toxicology.
[21] Alan R. Boobis,et al. IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans , 2008, Critical reviews in toxicology.
[22] G. Guyatt,et al. The GRADE approach and Bradford Hill's criteria for causation , 2010, Journal of Epidemiology & Community Health.
[23] Patrice Sutton,et al. An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. , 2011, Health affairs.
[24] A. B. Hill. The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.
[25] Causality and the interpretation of epidemiologic evidence. , 2007, Environmental health perspectives.
[26] E. Youngstrom,et al. A proposal to facilitate weight-of-evidence assessments: Harmonization of Neurodevelopmental Environmental Epidemiology Studies (HONEES). , 2011, Neurotoxicology and teratology.
[27] J. Vlaanderen,et al. Guidelines to Evaluate Human Observational Studies for Quantitative Risk Assessment , 2008, Environmental health perspectives.
[28] A. B. Hill,et al. "The Environment and Disease: Association or Causation?" (1965), by Austin Bradford Hill , 2017 .
[29] J. Goodman,et al. A framework for assessing causality and adverse effects in humans with a case study of sulfur dioxide. , 2010, Regulatory toxicology and pharmacology : RTP.
[30] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[31] Igor Linkov,et al. Weight-of-evidence evaluation in environmental assessment: review of qualitative and quantitative approaches. , 2009, The Science of the total environment.
[32] Carolyn Vickers,et al. IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .
[33] Glenn W Suter,et al. Why and how to combine evidence in environmental assessments: weighing evidence and building cases. , 2011, The Science of the total environment.
[34] James A. Swenberg,et al. Toxicology and Epidemiology: Improving the Science with a Framework for Combining Toxicological and Epidemiological Evidence to Establish Causal Inference , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[35] G. Swaen. A framework for using epidemiological data for risk assessment , 2006, Human & experimental toxicology.
[36] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[37] Igor Linkov,et al. Use of Multicriteria Decision Analysis to Support Weight of Evidence Evaluation , 2011, Risk analysis : an official publication of the Society for Risk Analysis.
[38] A. Zuckerman,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.
[39] Jennifer Seed,et al. Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data , 2005, Critical reviews in toxicology.
[40] E. V. Sargent,et al. IS HEXAVALENT CHROMIUM CARCINOGENIC VIA INGESTION? A WEIGHT-OF-EVIDENCE REVIEW , 2002, Journal of toxicology and environmental health. Part A.
[41] Vern R. Walker. RISK CHARACTERIZATION AND THE WEIGHT OF EVIDENCE : ADAPTING GATEKEEPING CONCEPTS FROM THE COURTS , 1996 .
[42] D. Weed. Weight of Evidence: A Review of Concept and Methods , 2005, Risk analysis : an official publication of the Society for Risk Analysis.
[43] Ord,et al. Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens , 2013 .
[44] Siobhan M. Dolan,et al. Assessment of cumulative evidence on genetic associations: interim guidelines. , 2008, International journal of epidemiology.
[45] J. Higgins,et al. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .
[46] Gordon H Guyatt,et al. GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .
[47] A. Boobis,et al. The Key Events Dose-Response Framework: A Cross-Disciplinary Mode-of-Action Based Approach to Examining Dose-Response and Thresholds , 2009, Critical reviews in food science and nutrition.
[48] Ord,et al. Guidelines for Developmental Toxicity Risk Assessment , 2014 .
[49] Rosa García Couto. Globally Harmonized System of Classification and Labelling of Chemicals (GHS) , 2009 .
[50] R. Prueitt,et al. Hypothesis-based weight-of-evidence evaluation of the neurodevelopmental effects of chlorpyrifos , 2011, Critical reviews in toxicology.
[51] C. Emond,et al. A weight of evidence approach for the assessment of the ototoxic potential of industrial chemicals , 2012, Toxicology and industrial health.
[52] Christopher Bevan,et al. Best Practices for Evaluating Method Validity, Data Quality and Study Reliability of Toxicity Studies for Chemical Hazard and Risk Assessments , 2013 .
[53] R. Preston,et al. Application of Key Events Analysis to Chemical Carcinogens and Noncarcinogens , 2009, Critical reviews in food science and nutrition.
[54] Guidance for Industry : Evidence-Based Review System for the Scientific Evaluation of Health Claims-Final , 2010 .
[55] Koji Arizono,et al. Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A , 2008, Environmental health perspectives.
[56] Ord,et al. Guidelines for Mutagenicity Risk Assessment , 2013 .
[57] M Younes,et al. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.
[58] Office on Smoking. The Health Consequences of Smoking: A Report of the Surgeon General , 2004 .